Education
About Us
Working with TipRanks
Follow Us
iZafe Group AB (DE:M02)
STUTTGART:M02
M02 Stock Chart & Stats
€0.04
€0.00(0.00%)
At close: 4:00 PM EST
€0.04
€0.00(0.00%)
Day’s Range― - ―
52-Week Range<€0.01 - €0.07
Previous CloseN/A
Volume0.00
Average Volume (3M)1.81K
Market Cap
€18.06M
Enterprise Value€83.50M
Total Cash (Recent Filing)€4.85M
Total Debt (Recent Filing)€333.00K
Price to Earnings (P/E)―
Beta0.73
Next Earnings
Feb 16, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding364,614,440
10 Day Avg. Volume0
30 Day Avg. Volume1,810
Financial Highlights & Ratios
PEG Ratio0.06
Price to Book (P/B)6.06
Price to Sales (P/S)7.41
P/FCF Ratio-4.64
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusHold
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
M02 FAQ
What was iZafe Group AB’s price range in the past 12 months?
iZafe Group AB lowest stock price was <€0.01 and its highest was €0.07 in the past 12 months.
What is iZafe Group AB’s market cap?
iZafe Group AB’s market cap is €18.06M.
When is iZafe Group AB’s upcoming earnings report date?
iZafe Group AB’s upcoming earnings report date is Feb 16, 2026 which is in 62 days.
How were iZafe Group AB’s earnings last quarter?
iZafe Group AB released its earnings results on Nov 03, 2025. The company reported >-€0.001 earnings per share for the quarter, missing the consensus estimate of N/A by >-€0.001.
Is iZafe Group AB overvalued?
According to Wall Street analysts iZafe Group AB’s price is currently Overvalued.
Does iZafe Group AB pay dividends?
iZafe Group AB does not currently pay dividends.
What is iZafe Group AB’s EPS estimate?
iZafe Group AB’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does iZafe Group AB have?
iZafe Group AB has 364,614,440 shares outstanding.
What happened to iZafe Group AB’s price movement after its last earnings report?
iZafe Group AB reported an EPS of >-€0.001 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -3.636%.
Which hedge fund is a major shareholder of iZafe Group AB?
Currently, no hedge funds are holding shares in DE:M02
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
iZafe Group AB
iZafe Group AB (publ), a life-science company, engages in the research, development, and marketing of digital medical solutions and services for safer drug management at home. The company provides Dosell, an automated drug dispenser that handles dose bags, facilitates and enables independent medication, and reminds and alerts if the current dose is not taken at the right time. It serves consumers, and public and private-sector care providers in Sweden, the Nordic region, and internationally. The company was formerly known as MediRätt AB (publ) and changed its name to iZafe Group AB (publ) in May 2019. iZafe Group AB (publ) was incorporated in 2008 and is headquartered in Stockholm, Sweden.
Technical Analysis
Biosergen AB
―
Lipigon Pharmaceuticals AB
―
NextCell Pharma AB
―
Spago Nanomedical AB
―
Iconovo AB
―